FDA Inspection 1206246 — Medstar Health Research Institute IRB
The FDA completed an inspection of Medstar Health Research Institute IRB on May 11, 2023 in Hyattsville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 11, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyattsville, MD (United States)
Additional Details
IRB